G. Cartron, L. Dacheux, G. Salles, P. Solal-celigny, P. Bardos et al., Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor Fcgamma RIIIa gene, Blood, vol.99, issue.3, pp.754-758, 2002.
DOI : 10.1182/blood.V99.3.754

W. K. Weng and R. Levy, Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular Lymphoma, Journal of Clinical Oncology, vol.21, issue.21, pp.3940-3947, 2003.
DOI : 10.1200/JCO.2003.05.013

A. Musolino, N. Naldi, B. Bortesi, D. Pezzuolo, M. Capelletti et al., ???Positive Metastatic Breast Cancer, Journal of Clinical Oncology, vol.26, issue.11, pp.1789-1796, 2008.
DOI : 10.1200/JCO.2007.14.8957

F. Bibeau, E. Lopez-crapez, F. Di-fiore, S. Thezenas, M. Ychou et al., Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan, Journal of Clinical Oncology, vol.27, issue.7, pp.1122-1129, 2009.
DOI : 10.1200/JCO.2008.18.0463

R. J. Taylor, V. Saloura, A. Jain, O. Goloubeva, S. Wong et al., Ex Vivo Antibody-Dependent Cellular Cytotoxicity Inducibility Predicts Efficacy of Cetuximab, Cancer Immunology Research, vol.3, issue.5, pp.567-574, 2015.
DOI : 10.1158/2326-6066.CIR-14-0188

U. J. Seidel, P. Schlegel, and P. Lang, Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies, Frontiers in Immunology, vol.4, p.76, 2013.
DOI : 10.3389/fimmu.2013.00076
URL : http://doi.org/10.3389/fimmu.2013.00076

W. Wang, A. K. Erbe, J. A. Hank, Z. S. Morris, P. M. Sondel et al., NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes, Blood, vol.107, pp.4669-4677, 2006.

K. Kudo, C. Imai, P. Lorenzini, T. Kamiya, K. Kono et al., T Lymphocytes Expressing a CD16 Signaling Receptor Exert Antibody-Dependent Cancer Cell Killing, Cancer Research, vol.74, issue.1, pp.93-103
DOI : 10.1158/0008-5472.CAN-13-1365

F. Ochi, H. Fujiwara, K. Tanimoto, H. Asai, Y. Miyazaki et al., Gene-Modified Human ??/??-T Cells Expressing a Chimeric CD16-CD3?? Receptor as Adoptively Transferable Effector Cells for Anticancer Monoclonal Antibody Therapy, Cancer Immunology Research, vol.2, issue.3, pp.249-262, 2014.
DOI : 10.1158/2326-6066.CIR-13-0099-T

M. Poon, Y. C. Linn, N. Shimasaki, L. K. Tan, L. P. Koh et al., A first-in-human study of autologous T lymphocytes with antibody-dependent cell cytotoxicity (ADCC) in patients with B-cell non-Hodgkin lymphoma (NHL) Effector memory alphabeta T lymphocytes can express FcgammaRIIIa and mediate antibodydependent cellular cytotoxicity, 58th Annual Meeting & Exposition, pp.5327-5334, 2008.

L. L. Lanier, G. Yu, and J. H. Phillips, Analysis of Fc gamma RIII (CD16) membrane expression and association with CD3 zeta and Fc epsilon RI-gamma by site-directed mutation, J. Immunol, vol.146, pp.1571-1576, 1991.

J. Cadi~-nanos and A. Bradley, Generation of an inducible and optimized piggyBac transposon system???, Nucleic Acids Research, vol.35, issue.12, p.87, 2007.
DOI : 10.1093/nar/gkm446

K. Yusa, L. Zhou, M. A. Li, A. Bradley, and N. L. Craig, A hyperactive piggyBac transposase for mammalian applications, Proc. Natl. Acad. Sci. USA, pp.1531-1536, 2011.
DOI : 10.1016/j.stem.2009.07.011
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029773

K. Yusa, R. Rad, J. Takeda, and A. Bradley, Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon, Nature Methods, vol.23, issue.5, pp.363-369, 2009.
DOI : 10.1038/nmeth.1323

S. Dall-'ozzo, C. Andres, P. Bardos, H. Watier, and G. Thibault, Rapid single-step FCGR3A genotyping based on SYBR Green I fluorescence in real-time multiplex allele-specific PCR, Journal of Immunological Methods, vol.277, issue.1-2, pp.185-192, 2003.
DOI : 10.1016/S0022-1759(03)00123-6

G. Gallot, S. Vollant, S. Sa¨?aghsa¨?agh, B. Cí-emenceau, R. Vivien et al., T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells, Journal of Immunotherapy, vol.37, issue.3, pp.170-179, 2014.
DOI : 10.1097/CJI.0000000000000031
URL : https://hal.archives-ouvertes.fr/hal-01256575

J. V. Pulvertaft, CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA), The Lancet, vol.283, issue.7327, pp.238-240, 1964.
DOI : 10.1016/S0140-6736(64)92345-1

H. R. Koene, M. Kleijer, J. Algra, D. Roos, A. E. Dem-borne et al., Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype, Levy, and H. Ví e. 2011. FcgRIIIa (CD16) induction on human T lymphocytes and CD16pos T-lymphocyte amplification, pp.1109-1114, 1997.

J. E. Christiaansen, S. S. Burnside, and D. W. Sears, Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC), J. Immunol, vol.138, pp.2236-2243, 1987.

E. Vivier, N. Rochet, M. Ackerly, J. Petrini, H. Levine et al., Signaling function of reconstituted CD16: ??: ?? receptor complex isoforms, International Immunology, vol.4, issue.11, pp.1313-1323, 1992.
DOI : 10.1093/intimm/4.11.1313